ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 68 filers reported holding ADC THERAPEUTICS SA in Q3 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $10,847,831 | -22.8% | 2,824,956 | -3.1% | 0.01% | -28.6% |
Q3 2022 | $14,051,000 | -40.3% | 2,915,160 | -1.6% | 0.01% | -36.4% |
Q2 2022 | $23,545,000 | -45.8% | 2,961,624 | +0.2% | 0.01% | -35.3% |
Q1 2022 | $43,439,000 | -23.4% | 2,957,056 | +5.3% | 0.02% | -15.0% |
Q4 2021 | $56,716,000 | -21.3% | 2,807,723 | +5.8% | 0.02% | -28.6% |
Q3 2021 | $72,089,000 | -3.0% | 2,654,217 | -13.1% | 0.03% | -6.7% |
Q2 2021 | $74,347,000 | +15.8% | 3,053,248 | +16.1% | 0.03% | +7.1% |
Q1 2021 | $64,210,000 | +11.4% | 2,630,491 | +46.1% | 0.03% | +3.7% |
Q4 2020 | $57,642,000 | +34.6% | 1,800,736 | +38.7% | 0.03% | +17.4% |
Q3 2020 | $42,840,000 | -1.3% | 1,298,565 | +40.0% | 0.02% | -11.5% |
Q2 2020 | $43,420,000 | – | 927,577 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |